Kymos Acquires Italian Firm Pharmaprogress
Spanish CRO, Kymos Pharma Services, announced that it has acquired Pharmaprogress, an Italian firm based in Ancona, specializing in contract research and analysis services.
Spanish CRO, Kymos Pharma Services, announced that it has acquired Pharmaprogress, an Italian firm based in Ancona, specializing in contract research and analysis services. Pharmaprogress has a 700-m2 analysis laboratory that is GMP authorized by the Italian Medicines Agency. The company is expected to deliver a turnover of EUR1 million in 2017.
Founded in 2001, Kymos has since worked on expanding internationally. With the acquisition of Pharmaprogress, Kymos estimates that 50% of its business volume will be generated outside Spain. Kymos’ main markets are Italy, France, Switzerland, Germany, and Portugal.
Source: Kymos
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
